A new dual-target CAR-T therapy improves follicular lymphoma control in preclinical models
A study led by researchers from the Hospital Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Centre, has identified CD70 as a mark...
A study led by researchers from the Hospital Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Centre, has identified CD70 as a mark...
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples...
Three visits have been organised this year: two focused on a research project on genetic alterations in patients with follicular lymphoma and one o...
The project led by Patricia Pérez Galán, the head of IDIBAPS’ Microenvironment in lymphoma pathogenesis and therapy research group, is the continua...
From 3 to 7 July, Arnau Guerrero and Meritxell Solana, two students who won the Extraordinary Baccalaureate Award for the 2021-2022 academic year,...
Led by Patricia Pérez-Galán, the study shows that the system, which uses patient-derived cells, recapitulates the biological and molecular characte...
In the next three years, the projects selected, led by Elías Campo, Patrícia Pérez Galán and Josep Dalmau, are aimed at studying how cancer cells m...
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives...
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new p...